Lynch Syndrome I
Description
Hereditary nonpolyposis colorectal cancer (HNPCC) is subdivided into (1) Lynch syndrome I, or site-specific colonic cancer, and (2) Lynch syndrome II, or extracolonic cancer, particularly carcinoma of the stomach, endometrium (see {608089}), biliary and pancreatic system, and urinary tract (Lynch and Lynch, 1979; Lynch et al., 1985; Mecklin and Jarvinen, 1991). HNPCC disorders show a proclivity to early onset, predominant proximal location of colon cancer, a dominant pattern of inheritance, an excess of multiple primary cancers, and significantly improved survival when compared stage for stage with the American College of Surgeons Audit Series.Lynch et al. (1991) estimated that hereditary nonpolyposis colorectal cancer accounts for about 4 to 6% of colorectal cancer. The minimum criterion of HNPCC is that colorectal carcinoma is diagnosed and histologically verified in at least 3 relatives belonging to 2 or more successive generations. Moreover, the age of onset should be less than 50 years in at least 1 patient.The Muir-Torre syndrome (MRTES ) is a form of Lynch syndrome II associated with sebaceous skin tumors.
Clinical Features
Top most frequent phenotypes and symptoms related to Lynch Syndrome I
- Neoplasm
- Carcinoma
- Leukemia
- Neoplasm of the skin
- Breast carcinoma
- Sarcoma
- Colon cancer
- Ovarian neoplasm
- Neoplasm of the pancreas
- Prostate cancer
And another 7 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Lynch Syndrome I Is also known as colorectal cancer, hereditary nonpolyposis, type 1, fcc1, hnpcc1, coca1, colon cancer, familial nonpolyposis, type 1.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Lynch Syndrome I Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
HNPCC MSI & IHC Screening.
By Baylor Miraca Genetics Laboratories (United States).
EPCAM, MLH1, MSH2, MSH6, PMS2
Specificity
20 %
Genes
100 % |
MSH2 Comprehensive - Sequence & Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
MSH2
Specificity
100 %
Genes
100 % |
MSH2 Deletion/Duplication Analysis.
By Baylor Miraca Genetics Laboratories (United States).
MSH2
Specificity
100 %
Genes
100 % |
MSH2 Sequence Analysis.
By Baylor Miraca Genetics Laboratories (United States).
MSH2
Specificity
100 %
Genes
100 % |
MSH2 Sequence Analysis (Familial Mutation/Variant Analysis).
By Baylor Miraca Genetics Laboratories (United States).
MSH2
Specificity
100 %
Genes
100 % |
Mismatch Repair Proteins Immunohistochemistry.
By Baylor Miraca Genetics Laboratories (United States).
MLH1, MSH2, MSH6, PMS2
Specificity
25 %
Genes
100 % |
Hereditary Brain, CNS, PNS Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
100 % |
Hereditary Brain, CNS, PNS Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
TP53, VHL, SUFU, PALB2, ALK, APC, MEN1, MLH1, MRE11, MSH2, MSH6, NBN, NF2, ATM, PMS2, PHOX2B, PTCH1
Specificity
6 %
Genes
100 % |
You can get up to 354 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY; SRTD14 HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7